Verily acquires SignalPath; Biden pushes for lower drug prices
This week's top stories include Verily beefing up its clinical trial platform, President Biden pushing for lower drug prices in his $3.5 trillion budget proposal, and the launch of the Teleprimary Care Certificate program.
